About Alvine Pharma
Alvine Pharma is a company based in San Carlos (United States) founded in 2005 was acquired by Immunogenx in March 2016.. Alvine Pharma has raised $128.51 million across 6 funding rounds from investors including AbbVie, Flagship Pioneering and Immunogenx. Alvine Pharma offers products and services including LLC Formation Service, Registered Agent Service, and Trademark Service. Alvine Pharma operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter San Carlos, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$128.51 M (USD)
in 6 rounds
-
Latest Funding Round
$70 M (USD), Series B
May 14, 2013
-
Investors
AbbVie
& 8 more
-
Employee Count
Employee Count
-
Acquired by
Immunogenx
(Mar 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alvine Pharma
Alvine Pharma offers a comprehensive portfolio of products and services, including LLC Formation Service, Registered Agent Service, and Trademark Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assists in forming limited liability companies for business owners.
Handles legal documents and ensures business compliance requirements.
Provides guidance on protecting business brands and trademarks.
Funding Insights of Alvine Pharma
Alvine Pharma has successfully raised a total of $128.51M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $70 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $70.0M
-
First Round
First Round
(01 May 2008)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2013 | Amount | Series B - Alvine Pharma | Valuation | AbbVie |
|
| Jan, 2013 | Amount | Series A - Alvine Pharma | Valuation |
investors |
|
| Oct, 2011 | Amount | Debt – Convertible - Alvine Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alvine Pharma
Alvine Pharma has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie, Flagship Pioneering and Immunogenx. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & later stage venture capital firm investing in the US
|
Founded Year | Domain | Location | |
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and healthtech firms.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alvine Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alvine Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alvine Pharma Comparisons
Competitors of Alvine Pharma
Alvine Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alvine Pharma
When was Alvine Pharma founded?
Alvine Pharma was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Alvine Pharma located?
Alvine Pharma is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Is Alvine Pharma a funded company?
Alvine Pharma is a funded company, having raised a total of $128.51M across 6 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $6.01M, raised on May 01, 2008.
What does Alvine Pharma do?
Alvine is developing biologics to target autoimmuneinflammatory diseases. The companys initial focus targets celiac disease. Celiac disease is a gluten-induced autoimmune disease for which no drug therapy is presently available. Alvines lead product candidate, ALV003, is a combination protease engineered to digest gluten and is currently in phase 2b.
Who are the top competitors of Alvine Pharma?
Alvine Pharma's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
What products or services does Alvine Pharma offer?
Alvine Pharma offers LLC Formation Service, Registered Agent Service, and Trademark Service.
Who are Alvine Pharma's investors?
Alvine Pharma has 9 investors. Key investors include AbbVie, Flagship Pioneering, Immunogenx, Panorama Capital, and InterWest.